Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and

Wanjie Huang1, Xianhong Xu1, Wenqi Zhao1

  • 1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

Abstract

Insights

Refractory Mycoplasma pneumoniae pneumonia (RMPP) in children can be predicted by elevated C-reactive protein (CRP), lactate dehydrogenase (LDH), neutrophils, and lung consolidation. Early identification of these biomarkers aids in timely RMPP treatment.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Mycoplasma pneumoniae is a frequent cause of community-acquired pneumonia (CAP) in children.
  • While typically self-limiting, M. pneumoniae infections can progress to refractory pneumonia (RMPP).
  • Early identification of RMPP is crucial for effective treatment.

Purpose of the Study:

  • To analyze clinical characteristics of C-reactive protein (CRP), lactate dehydrogenase (LDH), erythrocyte sedimentation rate (ESR), D-dimer, neutrophils, lymphocytes, and lung consolidation in RMPP.
  • To explore the predictive value of these markers in the early stages of RMPP.

Main Methods:

  • A systematic literature search was conducted across multiple databases (PubMed, Embase, Web of Science, etc.) up to February 23, 2021.
  • Meta-analysis was performed using mean difference (MD) with 95% confidence intervals (CI) for continuous variables.
  • Odds ratios (OR) with 95% CI were used to evaluate the correlation between lung consolidation and RMPP.

Main Results:

  • Elevated CRP, LDH, neutrophils, and increased risk of lung consolidation were observed in RMPP patients compared to non-RMPP cases.
  • D-dimer showed a non-significant trend towards elevation in RMPP.
  • No significant differences in ESR or lymphocyte percentages were found between RMPP and non-RMPP groups.

Conclusions:

  • CRP, LDH, neutrophils, and lung consolidation are identified as significant predictive factors for RMPP in children.
  • These biomarkers can aid in the early diagnosis and management of refractory Mycoplasma pneumoniae pneumonia.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
422
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
438
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
322
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
35
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
500
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K